Skip to main content
Cureus logoLink to Cureus
. 2024 May 14;16(5):e60247. doi: 10.7759/cureus.60247

Type 2 Diabetes Mellitus Prevalence and Associated Risk Factors in Postmenopausal Women

D Varalakshmi 1,2,, K Rekha 1, Rafi Mohammed 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC11170058  PMID: 38872669

Abstract

Introduction

Type 2 diabetes mellitus (T2DM) is the most common problem in postmenopausal women. This study aimed to find out the prevalence of T2DM and its risk factors in postmenopausal women.

Methods

The study is a population-based cross-sectional study. Anthropometric measurements, blood pressure, and biochemical measurements of 2295 postmenopausal women up to the age of 55 years were taken following face-to-face interviews. Odds ratio was used to find out the role of risk factors associated with T2DM.

Results

Prevalence of T2DM was reported to be 15.51%. Significant contribution of waist circumference (WC) followed by body mass index (BMI), total cholesterol (TC), and triglycerides (p<0.05) was noted in increasing the risk of T2DM. No association was found between T2DM and hypertension (p>0.05).

Conclusion

A high prevalence of T2DM was reported in postmenopausal women. Higher levels of BMI, WC, TC, and triglycerides were found to be the major risk factors for T2DM.

Keywords: blood pressure, triglycerides, total cholesterol, waist circumference, body mass index, risk factors, postmenopausal women, type 2 diabetes mellitus

Introduction

The clinical and economic burden associated with diabetes mellitus and its management remains an enduring challenge to the healthcare community [1]. It is well known that menopause status affects estrogen level [2] which plays an important role in regulating glucose homeostasis [3,4] and fat metabolism [5,6]. In menopause, a decrease in estrogen level caused by the depletion of ovarian function results in an increase in abdominal fat [7]. These alterations in body composition may possibly affect insulin sensitivity and glucose metabolism in postmenopausal women [8].

Type 2 diabetes mellitus (T2DM) is the most common type of diabetes mellitus, also known as insulin-resistant diabetes mellitus, a heterogeneous group of disorders characterized by different levels of impaired insulin secretion, insulin resistance, and increased production of glucose. In T2DM, either the insulin production is insufficient or the insulin cannot be used effectively by the body. Lower levels of the estrogen and progesterone hormones and also human growth hormone are some of the main reasons for T2DM in women over the age of 40. The insufficient production of the hormones contributes to lower metabolism and obesity which in turn is the main cause of T2DM [9].

Previously, several studies analyzed the association between menopause and T2DM. However, the analysis is not simple and straightforward because of multiple interrelating factors that may curtail the original clinical manifestations [10]. This study was undertaken to find out the prevalence of T2DM in postmenopausal women, to identify the risk factors for T2DM, and to assess its impact on the menopause age and the symptoms of climacteric disorders.

Materials and methods

A population-based cross-sectional study was conducted involving 2295 postmenopausal women. The participants were the patients from the outpatient department who consulted in a medical center and the companions of the patients. Postmenopausal women up to the age of 55 years were included. Women who underwent any gynecological surgeries were excluded from the study. The study was conducted between July 2022 and January 2023. Approval was obtained from the Institutional Ethical Committee of Apollo Institute of Medical Sciences and Research, Hyderabad (approval number: EC/AIMSR/1527/2022/05/17).

Data collection

Data collection was done through face-to-face interviews followed by physical measurements and the collection of blood samples from the participants. The face-to-face interview was conducted using a questionnaire to collect information on age, educational status, marital status, occupation, and history of blood pressure and diabetes (see Appendices). Relevant equipment and procedures were used for anthropometric measurements, blood pressure, and biochemical measurements.

Height was measured in centimeters and weight was recorded in kilograms. Body mass index (BMI) was determined by height and weight measurements. The Asia-Pacific classification of BMI was used to categorize the participants into normal weight (BMI=18.5-22.9), overweight (BMI=23-24.9), and obese (BMI ≥25) [11]. A constant tension tape was used to measure the waist circumference (WC) as per the STEPS Manual guideline (WHO STEPwise approach to non-communicable disease (NCD) risk factor surveillance) [12]. A WC of 80 cm was taken as a cutoff point [13].

Participants were considered diabetic if the fasting glucose level was ≥126 mg or the postprandial blood glucose level was ≥200 mg or if they were already on anti-diabetic medication at the time of this study [14]. Doctor's aneroid sphygmomanometer was used to measure blood pressure. During the study, the participants were considered hypertensive if the systolic blood pressure was >140 mm of Hg and/or the diastolic blood pressure was >90 mmHg or if they were previously diagnosed as having hypertension.

Statistical analysis

Descriptive statistics was used to analyze the data. The values were expressed in mean, frequencies, and percentages. Odds ratio was used to find out the role of risk factors associated with T2DM. A p-value of <0.05 was considered statistically significant. GraphPad Prism 10.2 was used to perform all analyses.

Results

A total of 2295 subjects participated in the study. The study findings revealed that the mean age of the participants was 51.18 years. Table 1 shows that 2274 out of 2295 participants (99.08%) were married. Many participants, i.e., 1629 out of 2295 (70.98%), were literate (completed high school education). Of the 2295, housewives were 1156 (50.37%). The BMI of 925 (40.3%) participants was ≥25 kg/m2. WC was also found to be higher than the normal levels in 949 (41.35%) participants.

Table 1. General and disease-specific characteristics of the subjects.

BMI: body mass index; WC; waist circumference

Characteristics Frequency Percent
Age group    
    ≤50 1709 74.46
    >50 586 25.53
Educational status    
   Completed schooling 1629 71
   Did not complete schooling 666 29
Occupation    
   Employees 1139 49.62
   Housewives 1156 50.37
Marital status    
   Married 2274 99.08
   Unmarried 21 0.91
BMI    
    ≥25 kg/m2 925 40.30
    <25 kg/m2 1370 59.69
WC    
    ≥80 949 41.35
    <80 1346 58.64

Prevalence of T2DM was reported to be 15.51% (356 out of 2295). Table 2 presents the odds ratios of different variables in relation to T2DM in postmenopausal women. The risk of T2DM increased with BMI ≥25 (OR 2.79; p<0.0001). Increased risk of T2DM was also noted with WC (OR 4.52; p<0.0001), total cholesterol (TC) (OR 1.83; p<0.0001), and triglycerides (OR 1.70; p<0.0001). No significant association of T2DM was seen with increase in systolic blood pressures (OR 1.21; p=0.09) and diastolic blood pressures (OR 1.23; p=0.07).

Table 2. Risk of T2DM with other characteristics.

T2DM: type 2 diabetes mellitus; BMI: body mass index; WC: waist circumference; TG: triglycerides; TC: total cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure

*p<0.05 is statistically significant

Variable Odds ratio 95% of CI P-value*
BMI 2.79 2.2122-3.5232 <0.0001
WC 4.52 3.5329-5.8066 <0.0001
TC 1.83 1.4616-2.3036 <0.0001
TG 1.70 1.3567-2.1367 <0.0001
SBP 1.21 0.9685-1.5248 0.09
DBP 1.23 0.9824-1.5462 0.07

Discussion

Our findings suggest that postmenopausal status can be considered as a well-founded and most important cause of T2DM and its prevalence in postmenopausal women has reached a distressing level. Menopause is linked with aging itself, and that is the reason why we limited our analyses to women aged up to 55 years. Many epidemiologic studies stated that impaired fasting glucose [15], dyslipidemia [16], and obesity [17] increase following menopause and all these metabolic disorders increase the risk of T2DM [18]. We found in our study that the risk of T2DM was strongly linked with postmenopausal status and the risk of T2DM with postmenopausal status was higher with BMI and WC. A decrease in estrogen level is considered to be the main cause of weight gain in women after menopause. A decrease in estrogen levels with menopause is also associated with an increase in central fat [19], and it has emerged as a risk factor for diabetes, hypertension, hypertriglyceridemia, and cardiovascular diseases [20]. Our results are consistent with the findings of a multinational study that found BMI and WC above normal levels were the risk factors for T2DM [21]. Our results also agree with the previous studies that assessed some of these parameters which are risk factors for diabetes. For instance, a Nigerian study [20] compared two groups of women with different levels of BMI and found that the risk for diabetes was higher in women with higher levels of BMI. In this way, menopause is followed by redistribution of adipose tissue to visceral depots and is associated with insulin resistance. It is widely accepted that being overweight or obese is predominantly related to diabetes. However, there is an increased risk of diabetes in Asians with a relatively lower BMI compared to the Western population [22]. The changes in body composition which take place after menopause are linked to impaired insulin sensitivity. It has also been demonstrated that abdominal obesity and impairments in both glucose tolerance [23] and insulin sensitivity [24] are associated independently among postmenopausal women. However, this relationship between abdominal obesity and insulin resistance has been well established even in the general population in several studies [25].

Other important risk factors of T2DM in postmenopausal women in our study were TC and triglycerides. These results are in line with previous studies. For example, the prevalence of T2DM was associated with dyslipidemia in a study conducted by Li et al. [26]. Another study indicated that the risk of diabetes increases with increased triglyceride levels [27]. It has been suggested in several epidemiologic studies that the incidence of dyslipidemia [16], obesity [15], and abnormal fasting blood glucose [17] increases in postmenopausal women and all these metabolic abnormalities are risk factors for T2DM [18]. Interestingly, no association was found between diabetes mellitus and hypertension in our study. Both systolic and diastolic blood pressures were not considerable risk factors for diabetes mellitus. These findings are quite different from what has been found in previous studies which demonstrated that the risk of diabetes mellitus increases with hypertension [19,26,27]. In a Women's Health study, it was suggested that hypertension is a strong predictor for the development of T2DM [28]. Hypertension was the main risk factor for diabetes mellitus in a study of a large number of women with climacteric symptoms [29]. It is well established that hypertension is very common in women with diabetes, since there is an extensive overlap between hypertension and diabetes in their etiology and mechanism of disease. This is because obesity leads to inflammation followed by insulin resistance and oxidative stress [30].

There has been a sharp increase in the prevalence of T2DM in postmenopausal women, and organizations have to gear up for urgent population-based interventions to prevent or delay its onset.

Study limitations

Our study limitation is that only a few variables were tested due to cost constraints.

Conclusions

The findings of our population-based cross-sectional study demonstrate that the prevalence of T2DM is high among postmenopausal women. WC, BMI, TC, and triglycerides were found to be the major risk factors for T2DM in postmenopausal women.

Appendices

Questionnaire

Name:

Age:

Height:

Weight:

1.     What is your highest qualification?

2.     What is your marital status?

3.     What is your current employment status? 

4.     What is your annual income?

5.     Have you ever been diagnosed with diabetes?

6.     Have you ever been diagnosed with hypertension?

The authors have declared that no competing interests exist.

Author Contributions

Concept and design:  D Varalakshmi, K Rekha, Rafi Mohammed

Acquisition, analysis, or interpretation of data:  D Varalakshmi, K Rekha, Rafi Mohammed

Drafting of the manuscript:  D Varalakshmi, K Rekha, Rafi Mohammed

Critical review of the manuscript for important intellectual content:  D Varalakshmi, K Rekha, Rafi Mohammed

Supervision:  D Varalakshmi

Human Ethics

Consent was obtained or waived by all participants in this study. Institutional Ethical Committee of Apollo Institute of Medical Sciences and Research issued approval EC/AIMSR/1527/2022/05/17

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.New and emerging drugs and targets for type 2 diabetes: reviewing the evidence. Miller BR, Nguyen H, Hu CJ, Lin C, Nguyen QT. https://pubmed.ncbi.nlm.nih.gov/25558307/ Am Health Drug Benefits. 2014;7:452–463. [PMC free article] [PubMed] [Google Scholar]
  • 2.Quantification of ovarian stromal Doppler signals in postmenopausal women receiving hormone replacement therapy. Pan HA, Li CH, Cheng YC, Wu MH, Chang FM. Menopause. 2003;10:366–372. doi: 10.1097/01.GME.0000055486.06076.DB. [DOI] [PubMed] [Google Scholar]
  • 3.Estrogen prevents high-glucose-induced damage of retinal ganglion cells via mitochondrial pathway. Hao M, Li Y, Lin W, Xu Q, Shao N, Zhang Y, Kuang H. Graefes Arch Clin Exp Ophthalmol. 2015;253:83–90. doi: 10.1007/s00417-014-2771-7. [DOI] [PubMed] [Google Scholar]
  • 4.The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in American Indian postmenopausal women: the Strong Heart Study. Zhang Y, Howard BV, Cowan LD, et al. Diabetes Care. 2002;25:500–504. doi: 10.2337/diacare.25.3.500. [DOI] [PubMed] [Google Scholar]
  • 5.Can the effects of gender, menopause and ageing on lipid levels be differentiated? Nikolic D, Banach M, Mikhailidis DP, Rizzo M. Clin Endocrinol (Oxf) 2016;85:694–695. doi: 10.1111/cen.13159. [DOI] [PubMed] [Google Scholar]
  • 6.Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Acta Physiol (Oxf) 2011;203:259–269. doi: 10.1111/j.1748-1716.2010.02237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Influence of menopause on diabetes and diabetes risk. Szmuilowicz ED, Stuenkel CA, Seely EW. Nat Rev Endocrinol. 2009;5:553–558. doi: 10.1038/nrendo.2009.166. [DOI] [PubMed] [Google Scholar]
  • 8.Estrogen deficiency and the origin of obesity during menopause. Lizcano F, Guzmán G. Biomed Res Int. 2014;2014:757461. doi: 10.1155/2014/757461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy. Menopause. 2001;8:290–295. doi: 10.1097/00042192-200107000-00012. [DOI] [PubMed] [Google Scholar]
  • 10.Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. doi: 10.1016/S0140-6736(03)15268-3. [DOI] [PubMed] [Google Scholar]
  • 11.The WHO STEPwise approach to noncommunicable disease risk factor surveillance. World Health Organization. 2017;36:1–474. [Google Scholar]
  • 12.Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. https://pubmed.ncbi.nlm.nih.gov/12485966/ Circulation. 2002;106:3143–3421. [PubMed] [Google Scholar]
  • 13.Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:0–9. doi: 10.2337/dc10-S062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.The burden and determinants of non communicable diseases risk factors in Nepal: findings from a nationwide STEPS survey. Aryal KK, Mehata S, Neupane S, et al. PLoS One. 2015;10:0. doi: 10.1371/journal.pone.0134834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Are blood glucose levels affected by menopause? Freeman R. Menopause. 2007;14:350–351. doi: 10.1097/gme.0b013e31804f8186. [DOI] [PubMed] [Google Scholar]
  • 16.Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia. Igase M, Kohara K, Tabara Y, et al. Menopause. 2012;19:1294–1299. doi: 10.1097/gme.0b013e318259c04e. [DOI] [PubMed] [Google Scholar]
  • 17.Sedentary lifestyle in middle-aged women is associated with severe menopausal symptoms and obesity. Blümel JE, Fica J, Chedraui P, et al. Menopause. 2016;23:488–493. doi: 10.1097/GME.0000000000000575. [DOI] [PubMed] [Google Scholar]
  • 18.Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Zhou H, Guo ZR, Yu LG, et al. Diabetes Res Clin Pract. 2010;90:319–325. doi: 10.1016/j.diabres.2010.09.001. [DOI] [PubMed] [Google Scholar]
  • 19.Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Diabetes Obes Metab. 2006;8:538–554. doi: 10.1111/j.1463-1326.2005.00545.x. [DOI] [PubMed] [Google Scholar]
  • 20.Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? Scheen AJ. Diabetes Metab. 2005;31:5–34. doi: 10.1016/s1262-3636(05)73649-1. [DOI] [PubMed] [Google Scholar]
  • 21.Type II diabetes mellitus and menopause: a multinational study. Monterrosa-Castro A, Blümel JE, Portela-Buelvas K, et al. Climacteric. 2013;16:663–672. doi: 10.3109/13697137.2013.798272. [DOI] [PubMed] [Google Scholar]
  • 22.Obesity, insulin resistance and diabetes--a worldwide epidemic. Seidell JC. Br J Nutr. 2000;83:0–8. doi: 10.1017/s000711450000088x. [DOI] [PubMed] [Google Scholar]
  • 23.Relation of age, exercise, anthropometric measurements, and diet with glucose and insulin levels in a population aged 70 years and over. Campbell AJ, Busby WJ, Horwath CC, Robertson MC. Am J Epidemiol. 1993;138:688–696. doi: 10.1093/oxfordjournals.aje.a116906. [DOI] [PubMed] [Google Scholar]
  • 24.Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Sites CK, Calles-Escandón J, Brochu M, Butterfield M, Ashikaga T, Poehlman ET. Fertil Steril. 2000;73:61–65. doi: 10.1016/s0015-0282(99)00453-7. [DOI] [PubMed] [Google Scholar]
  • 25.Abdominal obesity and metabolic syndrome. Després JP, Lemieux I. Nature. 2006;444:881–887. doi: 10.1038/nature05488. [DOI] [PubMed] [Google Scholar]
  • 26.Epidemiological characteristics and risk factors of T2DM in Chinese premenopausal and postmenopausal women. Li Q, Wang X, Ni Y, et al. Lipids Health Dis. 2019;18:155. doi: 10.1186/s12944-019-1091-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Association of menopause and type 2 diabetes mellitus. Ren Y, Zhang M, Liu Y, et al. Menopause. 2019;26:325–330. doi: 10.1097/GME.0000000000001200. [DOI] [PubMed] [Google Scholar]
  • 28.Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Eur Heart J. 2007;28:2937–2943. doi: 10.1093/eurheartj/ehm400. [DOI] [PubMed] [Google Scholar]
  • 29.Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. Di Donato P, Giulini NA, Bacchi Modena A, et al. Climacteric. 2005;8:287–293. doi: 10.1080/13697130500196866. [DOI] [PubMed] [Google Scholar]
  • 30.Diabetes and hypertension: is there a common metabolic pathway? Cheung BM, Li C. Curr Atheroscler Rep. 2012;14:160–166. doi: 10.1007/s11883-012-0227-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES